SPIEGELMAN DANIEL K
Insider CIK 1238403 · BMRN EVP, Chief Financial Officer · CYCC Director · AFFY Director · OMER Director · ANTH Director · ONTY Director · RLYP Director · VTVT Director · SPRB Director · MAZE Director · KYTX Director · MYGN Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| VTVT vTv Therapeutics Inc. | A Award deriv | 2026-06-26 | 2026-06-29 | 6,000 | $35.08 | $210.5K | 16,000 | SEC↗ |
| MAZE Maze Therapeutics, Inc. | A Award deriv | 2026-06-08 | 2026-06-10 | 18,000 | — | $0 | 18,000 | SEC↗ |
| SPRB SPRUCE BIOSCIENCES, INC. | A Award deriv | 2026-05-21 | 2026-05-26 | 1,700 | — | $0 | 1,700 | SEC↗ |
| SPRB SPRUCE BIOSCIENCES, INC. | D To issuer deriv | 2025-12-11 | 2025-12-15 | 400 | — | $0 | 0 | SEC↗ |
| SPRB SPRUCE BIOSCIENCES, INC. | D To issuer deriv | 2025-12-11 | 2025-12-15 | 458 | — | $0 | 0 | SEC↗ |
| SPRB SPRUCE BIOSCIENCES, INC. | A Award deriv | 2025-12-11 | 2025-12-15 | 458 | — | $0 | 458 | SEC↗ |
| SPRB SPRUCE BIOSCIENCES, INC. | A Award deriv | 2025-12-11 | 2025-12-15 | 88 | — | $0 | 88 | SEC↗ |
| SPRB SPRUCE BIOSCIENCES, INC. | A Award deriv | 2025-12-11 | 2025-12-15 | 400 | — | $0 | 400 | SEC↗ |
| SPRB SPRUCE BIOSCIENCES, INC. | D To issuer deriv | 2025-12-11 | 2025-12-15 | 88 | — | $0 | 0 | SEC↗ |
| MAZE Maze Therapeutics, Inc. | A Award deriv | 2025-09-22 | 2025-09-24 | 18,000 | — | $0 | 18,000 | SEC↗ |
| SPRB SPRUCE BIOSCIENCES, INC. | A Award deriv | 2025-07-22 | 2025-07-24 | 30,000 | — | $0 | 30,000 | SEC↗ |
| VTVT vTv Therapeutics Inc. | A Award deriv | 2025-06-10 | 2025-06-12 | 4,000 | $16.59 | $66.4K | 10,000 | SEC↗ |
| KYTX Kyverna Therapeutics, Inc. | A Award deriv | 2025-05-29 | 2025-06-02 | 65,351 | — | $0 | 65,351 | SEC↗ |
| KYTX Kyverna Therapeutics, Inc. | A Award | 2025-05-29 | 2025-06-02 | 16,634 | — | $0 | 16,634 | SEC↗ |
| VTVT vTv Therapeutics Inc. | A Award deriv | 2024-06-25 | 2024-06-27 | 6,000 | $17.22 | $103.3K | 6,000 | SEC↗ |
| MYGN MYRIAD GENETICS INC | S Sale | 2024-06-04 | 2024-06-04 | 3,788 | $22.05 | $83.5K | 32,917 | SEC↗ |
| MYGN MYRIAD GENETICS INC | S Sale | 2024-06-03 | 2024-06-04 | 3,788 | $22.04 | $83.5K | 36,705 | SEC↗ |
| SPRB SPRUCE BIOSCIENCES, INC. | A Award deriv | 2024-05-22 | 2024-05-24 | 30,000 | — | $0 | 30,000 | SEC↗ |
| MYGN MYRIAD GENETICS INC | S Sale | 2023-06-02 | 2023-06-02 | 8,638 | $23.01 | $198.8K | 40,493 | SEC↗ |
| MYGN MYRIAD GENETICS INC | A Award | 2023-06-01 | 2023-06-02 | 15,151 | — | $0 | 49,131 | SEC↗ |
| SPRB SPRUCE BIOSCIENCES, INC. | A Award deriv | 2023-05-25 | 2023-05-26 | 30,000 | — | $0 | 30,000 | SEC↗ |
| MYGN MYRIAD GENETICS INC | S Sale | 2022-06-06 | 2022-06-06 | 6,424 | $19.25 | $123.7K | 33,980 | SEC↗ |
| MYGN MYRIAD GENETICS INC | A Award | 2022-06-02 | 2022-06-03 | 17,275 | — | $0 | 40,404 | SEC↗ |
| SPRB SPRUCE BIOSCIENCES, INC. | A Award deriv | 2022-05-25 | 2022-05-27 | 22,500 | — | $0 | 22,500 | SEC↗ |
| MYGN MYRIAD GENETICS INC | S Sale | 2021-06-17 | 2021-06-17 | 3,139 | $30.52 | $95.8K | 23,129 | SEC↗ |
| MYGN MYRIAD GENETICS INC | A Award | 2021-06-03 | 2021-06-04 | 12,848 | — | $0 | 26,268 | SEC↗ |
| MYGN MYRIAD GENETICS INC | S Sale | 2021-05-28 | 2021-06-01 | 7,142 | $28.99 | $207.0K | 13,420 | SEC↗ |
| MYGN MYRIAD GENETICS INC | D To issuer | 2021-05-27 | 2021-05-28 | 15,889 | — | $0 | 20,562 | SEC↗ |
| SPRB SPRUCE BIOSCIENCES, INC. | A Award deriv | 2021-05-20 | 2021-05-21 | 6,667 | — | $0 | 6,667 | SEC↗ |
| MYGN MYRIAD GENETICS INC | A Award | 2020-12-04 | 2020-12-07 | 15,889 | — | $0 | 36,451 | SEC↗ |
| MYGN MYRIAD GENETICS INC | A Award | 2020-05-27 | 2020-05-28 | 20,562 | — | $0 | 20,562 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2019-04-30 | 2019-06-07 | 176 | $68.78 | $12.1K | 47,686 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2019-04-01 | 2019-04-03 | 13,473 | $89.00 | $1.20M | 47,510 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2019-03-27 | 2019-03-29 | 100 | $90.00 | $9.0K | 60,983 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2019-03-22 | 2019-03-26 | 3,598 | $88.05 | $316.8K | 61,083 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2019-03-15 | 2019-03-19 | 23,450 | — | $0 | 23,450 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2019-03-15 | 2019-03-19 | 7,227 | $94.53 | $683.2K | 55,311 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2019-03-15 | 2019-03-19 | 9,370 | — | $0 | 64,681 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2019-03-01 | 2019-03-05 | 12,205 | — | $0 | 63,450 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2019-03-01 | 2019-03-05 | 912 | $94.76 | $86.4K | 62,538 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2018-10-31 | 2018-12-20 | 175 | $68.78 | $12.0K | 51,245 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2018-06-22 | 2018-06-26 | 9,528 | $99.00 | $943.3K | 51,542 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2018-06-22 | 2018-06-26 | 472 | $99.01 | $46.7K | 51,070 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2018-06-04 | 2018-06-06 | 1,711 | $92.07 | $157.5K | 61,070 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2018-04-30 | 2018-06-06 | 167 | $68.78 | $11.5K | 62,781 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2018-04-23 | 2018-04-25 | 11,059 | $82.15 | $908.5K | 62,543 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2018-03-22 | 2018-04-27 | 3,598 | $81.36 | $292.7K | 73,587 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2018-03-22 | 2018-03-26 | 3,583 | $81.36 | $291.5K | 73,602 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2018-03-15 | 2018-03-19 | 39,900 | — | $0 | 39,900 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2018-03-15 | 2018-03-19 | 3,815 | $83.57 | $318.8K | 64,705 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2018-03-15 | 2018-03-19 | 12,480 | — | $0 | 77,185 | SEC↗ |
| CASC Cascadian Therapeutics, In | D To issuer deriv | 2018-03-09 | 2018-03-13 | 13,927 | — | $0 | 0 | SEC↗ |
| CASC Cascadian Therapeutics, In | U Tender | 2018-03-09 | 2018-03-13 | 21,006 | — | $0 | 0 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2018-03-02 | 2018-03-06 | 1,609 | $79.86 | $128.5K | 68,520 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2018-02-26 | 2018-04-26 | 12,615 | — | $0 | 70,215 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2018-02-26 | 2018-02-28 | 12,529 | — | $0 | 70,129 | SEC↗ |
| CASC Cascadian Therapeutics, In | M Exercise deriv | 2017-09-24 | 2017-09-26 | 2,375 | — | $0 | 0 | SEC↗ |
| CASC Cascadian Therapeutics, In | F Tax w/h | 2017-09-24 | 2017-09-26 | 594 | $3.94 | $2.3K | 21,006 | SEC↗ |
| CASC Cascadian Therapeutics, In | M Exercise | 2017-09-24 | 2017-09-26 | 2,375 | — | $0 | 21,600 | SEC↗ |
| CASC Cascadian Therapeutics, In | M Exercise deriv | 2017-06-24 | 2017-06-27 | 9,058 | — | $0 | 0 | SEC↗ |
| CASC Cascadian Therapeutics, In | M Exercise | 2017-06-24 | 2017-06-27 | 9,058 | — | $0 | 21,490 | SEC↗ |
| CASC Cascadian Therapeutics, In | F Tax w/h | 2017-06-24 | 2017-06-27 | 2,265 | $3.78 | $8.6K | 19,225 | SEC↗ |
| CASC Cascadian Therapeutics, In | M Exercise deriv | 2017-06-12 | 2017-06-13 | 2,148 | — | $0 | 0 | SEC↗ |
| CASC Cascadian Therapeutics, In | F Tax w/h | 2017-06-12 | 2017-06-13 | 537 | $3.34 | $1.8K | 12,432 | SEC↗ |
| CASC Cascadian Therapeutics, In | M Exercise | 2017-06-12 | 2017-06-13 | 2,148 | — | $0 | 12,969 | SEC↗ |
| CASC Cascadian Therapeutics, In | A Award deriv | 2017-06-09 | 2017-06-13 | 13,927 | — | $0 | 13,927 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2017-06-02 | 2017-06-06 | 1,801 | $90.72 | $163.4K | 23,303 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2017-05-15 | 2017-05-17 | 1,722 | $91.50 | $157.6K | 25,104 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2017-04-28 | 2017-05-17 | 155 | $70.30 | $10.9K | 26,826 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2017-03-22 | 2017-03-24 | 39,480 | — | $0 | 39,480 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2017-03-22 | 2017-03-24 | 12,200 | — | $0 | 26,671 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2017-03-16 | 2017-03-17 | 1,989 | $91.96 | $182.9K | 14,471 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2017-03-15 | 2017-03-17 | 4,301 | $92.50 | $397.8K | 16,460 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2017-03-06 | 2017-03-08 | 2,303 | $93.32 | $214.9K | 20,761 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2017-03-03 | 2017-03-07 | 2,283 | $93.95 | $214.5K | 23,064 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2017-03-01 | 2017-03-02 | 5,000 | $94.50 | $472.5K | 25,347 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2017-02-28 | 2017-03-02 | 30,000 | — | $0 | 21,700 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2017-02-28 | 2017-03-02 | 30,000 | $63.10 | $1.89M | 60,347 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2017-02-28 | 2017-03-02 | 30,000 | $94.00 | $2.82M | 30,347 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2017-02-24 | 2017-02-28 | 12,247 | — | $0 | 30,347 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2017-01-09 | 2017-01-10 | 5,000 | $90.00 | $450.0K | 18,100 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2016-11-09 | 2016-11-14 | 20,000 | $90.61 | $1.81M | 23,100 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2016-10-31 | 2016-11-14 | 156 | $68.44 | $10.7K | 43,100 | SEC↗ |
| RLYP Relypsa Inc | D To issuer deriv | 2016-09-01 | 2016-09-02 | 4,500 | — | $0 | 0 | SEC↗ |
| RLYP Relypsa Inc | D To issuer deriv | 2016-09-01 | 2016-09-02 | 12,000 | — | $0 | 0 | SEC↗ |
| RLYP Relypsa Inc | D To issuer deriv | 2016-09-01 | 2016-09-02 | 4,500 | — | $0 | 0 | SEC↗ |
| RLYP Relypsa Inc | U Tender | 2016-09-01 | 2016-09-02 | 1,237 | $32.00 | $39.6K | 2,250 | SEC↗ |
| RLYP Relypsa Inc | D To issuer | 2016-09-01 | 2016-09-02 | 2,250 | $32.00 | $72.0K | 0 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2016-08-01 | 2016-08-03 | 4,000 | $99.33 | $397.3K | 42,944 | SEC↗ |
| CASC Cascadian Therapeutics, In | A Award deriv | 2016-06-24 | 2016-06-28 | 54,347 | — | $0 | 54,347 | SEC↗ |
| RLYP Relypsa Inc | A Award deriv | 2016-06-21 | 2016-06-23 | 4,500 | — | $0 | 4,500 | SEC↗ |
| RLYP Relypsa Inc | A Award | 2016-06-21 | 2016-06-23 | 2,250 | — | $0 | 3,487 | SEC↗ |
| RLYP Relypsa Inc | S Sale | 2016-06-07 | 2016-06-08 | 1,013 | $19.31 | $19.6K | 1,237 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2016-06-06 | 2016-06-08 | 1,649 | $89.14 | $147.0K | 46,944 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2016-06-03 | 2016-06-07 | 1,801 | $90.00 | $162.1K | 48,593 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2016-05-31 | 2016-06-02 | 16,896 | — | $0 | 2,604 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2016-05-31 | 2016-06-08 | 16,896 | — | $0 | 2,604 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2016-05-31 | 2016-06-02 | 16,896 | $90.00 | $1.52M | 54,339 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2016-05-31 | 2016-06-02 | 3,945 | $89.35 | $352.5K | 50,394 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2016-05-31 | 2016-06-02 | 16,896 | $39.06 | $660.0K | 71,235 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2016-05-27 | 2016-05-31 | 4,305 | $89.09 | $383.5K | 54,339 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2016-05-23 | 2016-05-25 | 3,769 | $87.07 | $328.2K | 58,644 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2016-05-13 | 2016-05-17 | 1,722 | $82.71 | $142.4K | 62,413 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2016-04-29 | 2016-05-17 | 202 | $51.26 | $10.4K | 64,135 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2016-03-15 | 2016-03-17 | 37,290 | — | $0 | 37,290 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2016-03-15 | 2016-03-17 | 16,640 | — | $0 | 63,933 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2016-03-03 | 2016-03-07 | 2,395 | $89.57 | $214.5K | 47,293 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2016-03-02 | 2016-03-02 | 4,623 | $86.12 | $398.1K | 49,688 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2016-02-29 | 2016-03-02 | 46,766 | $81.87 | $3.83M | 54,311 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2016-02-24 | 2016-02-26 | 5,883 | — | $0 | 101,077 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2016-02-24 | 2016-02-26 | 49,600 | — | $0 | 95,194 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2016-02-24 | 2016-02-26 | 17,150 | — | $0 | 45,594 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2015-11-16 | 2015-11-18 | 20,000 | — | $0 | 19,500 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2015-11-16 | 2015-11-18 | 20,000 | $39.06 | $781.2K | 48,229 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2015-11-16 | 2015-11-18 | 20,000 | $104.30 | $2.09M | 28,229 | SEC↗ |
| ONTY Oncothyreon Inc. | A Award deriv | 2015-09-24 | 2015-09-28 | 14,245 | — | $0 | 14,245 | SEC↗ |
| ONTY Oncothyreon Inc. | M Exercise deriv | 2015-06-13 | 2015-06-16 | 16,042 | — | $0 | 0 | SEC↗ |
| ONTY Oncothyreon Inc. | M Exercise | 2015-06-13 | 2015-06-16 | 16,042 | — | $0 | 56,686 | SEC↗ |
| ONTY Oncothyreon Inc. | F Tax w/h | 2015-06-13 | 2015-06-16 | 4,011 | $3.88 | $15.6K | 52,675 | SEC↗ |
| ONTY Oncothyreon Inc. | A Award deriv | 2015-06-12 | 2015-06-16 | 12,886 | — | $0 | 12,886 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2015-06-05 | 2015-06-08 | 1,649 | $122.30 | $201.7K | 28,229 | SEC↗ |
| RLYP Relypsa Inc | A Award deriv | 2015-06-04 | 2015-06-08 | 4,500 | — | $0 | 4,500 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2015-06-04 | 2015-06-08 | 1,801 | $120.46 | $216.9K | 29,878 | SEC↗ |
| RLYP Relypsa Inc | A Award | 2015-06-04 | 2015-06-08 | 2,250 | — | $0 | 2,250 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2015-06-01 | 2015-06-03 | 3,945 | $124.16 | $489.8K | 31,679 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2015-05-29 | 2015-06-03 | 1,578 | $126.15 | $199.1K | 35,624 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2015-05-29 | 2015-06-03 | 4,305 | $125.57 | $540.6K | 37,202 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2015-05-27 | 2017-10-13 | 34,078 | — | $0 | 35,552 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2015-05-27 | 2017-10-13 | 34,078 | $130.00 | $4.43M | 75,585 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2015-05-27 | 2017-10-13 | 34,078 | $67.81 | $2.31M | 109,663 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2015-05-18 | 2015-05-19 | 2,059 | $124.77 | $256.9K | 75,585 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2015-05-18 | 2015-05-28 | 34,078 | $130.00 | $4.43M | 41,507 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2015-05-15 | 2015-05-19 | 1,722 | $122.78 | $211.4K | 77,644 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2015-04-30 | 2015-05-19 | 88 | $51.26 | $4.5K | 79,366 | SEC↗ |
| ONTY Oncothyreon Inc. | P Buy | 2015-03-26 | 2015-04-01 | 10,000 | $1.59 | $15.9K | 40,644 | SEC↗ |
| ONTY Oncothyreon Inc. | P Buy | 2015-03-26 | 2015-04-02 | 10,000 | $1.59 | $15.9K | 40,644 | SEC↗ |
| ONTY Oncothyreon Inc. | P Buy | 2015-03-25 | 2015-04-01 | 10,000 | $1.63 | $16.3K | 30,644 | SEC↗ |
| ONTY Oncothyreon Inc. | P Buy | 2015-03-25 | 2015-04-02 | 10,000 | $1.63 | $16.3K | 30,644 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2015-03-03 | 2015-03-05 | 23,900 | — | $0 | 23,900 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2015-03-03 | 2015-03-05 | 10,500 | — | $0 | 79,278 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2015-03-02 | 2015-03-04 | 15,500 | — | $0 | 39,500 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2015-03-02 | 2015-03-04 | 15,500 | $39.06 | $605.4K | 84,176 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2015-03-02 | 2015-03-04 | 15,500 | $107.00 | $1.66M | 68,676 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2014-09-03 | 2015-02-10 | 9 | $69.70 | $627 | 68,733 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2014-09-03 | 2015-02-10 | 9 | $69.83 | $628 | 68,742 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2014-09-02 | 2014-09-03 | 16,000 | — | $0 | 55,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2014-09-02 | 2014-09-03 | 16,000 | $69.83 | $1.12M | 68,676 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2014-09-02 | 2014-09-03 | 16,000 | $39.06 | $625.0K | 84,676 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2014-08-06 | 2015-02-10 | 7 | $62.18 | $435 | 68,751 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2014-08-06 | 2015-02-10 | 7 | $62.17 | $435 | 68,744 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2014-08-01 | 2014-08-04 | 2,229 | $61.76 | $137.7K | 68,676 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2014-07-02 | 2014-07-03 | 2,229 | $64.00 | $142.7K | 70,905 | SEC↗ |
| RLYP Relypsa Inc | A Award deriv | 2014-06-19 | 2014-06-23 | 12,000 | — | $0 | 12,000 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | A Award deriv | 2014-06-13 | 2014-06-16 | 12,500 | — | $0 | 12,500 | SEC↗ |
| ONTY Oncothyreon Inc. | F Tax w/h | 2014-06-07 | 2014-06-10 | 2,044 | $3.06 | $6.3K | 36,827 | SEC↗ |
| ONTY Oncothyreon Inc. | A Award deriv | 2014-06-06 | 2014-06-10 | 16,339 | — | $0 | 16,339 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2014-06-04 | 2014-06-06 | 51,700 | — | $0 | 51,700 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2014-06-04 | 2014-06-06 | 13,800 | — | $0 | 73,134 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2014-05-29 | 2014-06-02 | 3,792 | $57.50 | $218.0K | 59,334 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2014-05-15 | 2014-05-16 | 1,241 | $57.44 | $71.3K | 63,126 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2014-05-02 | 2015-02-10 | 8 | $58.78 | $470 | 68,737 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2014-05-02 | 2015-02-10 | 3 | $58.02 | $174 | 68,745 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2014-04-30 | 2014-05-16 | 94 | $49.50 | $4.7K | 64,367 | SEC↗ |
| ONTY Oncothyreon Inc. | M Exercise deriv | 2014-03-11 | 2014-03-12 | 19,352 | — | $0 | 0 | SEC↗ |
| ONTY Oncothyreon Inc. | M Exercise | 2014-03-11 | 2014-03-12 | 19,352 | — | $0 | 43,709 | SEC↗ |
| ONTY Oncothyreon Inc. | F Tax w/h | 2014-03-11 | 2014-03-12 | 4,838 | $3.65 | $17.7K | 38,871 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2014-03-05 | 2015-02-10 | 12 | $82.93 | $995 | 68,748 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2014-03-03 | 2014-03-05 | 8,000 | — | $0 | 71,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2014-03-03 | 2014-03-05 | 8,000 | $80.32 | $642.6K | 64,273 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2014-03-03 | 2014-03-05 | 8,000 | $39.06 | $312.5K | 72,273 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2014-02-14 | 2014-02-19 | 26,250 | — | $0 | 64,273 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2013-12-02 | 2013-12-04 | 9,000 | — | $0 | 79,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2013-12-02 | 2013-12-04 | 9,000 | $39.06 | $351.5K | 46,950 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2013-12-02 | 2013-12-04 | 9,000 | $70.14 | $631.3K | 37,950 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2013-11-20 | 2015-02-10 | 8 | $65.89 | $527 | 68,760 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2013-10-30 | 2015-02-10 | 5 | $65.75 | $329 | 68,752 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2013-10-30 | 2015-02-10 | 4 | $66.48 | $266 | 68,747 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2013-10-07 | 2015-02-10 | 6 | $74.84 | $449 | 68,743 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2013-10-04 | 2015-02-10 | 5 | $74.07 | $370 | 68,737 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2013-09-10 | 2015-02-10 | 7 | $70.30 | $492 | 68,732 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2013-09-10 | 2015-02-10 | 8 | $70.06 | $560 | 68,725 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2013-09-04 | 2013-09-05 | 9,000 | — | $0 | 88,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2013-09-04 | 2013-09-05 | 9,000 | $39.06 | $351.5K | 46,950 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2013-09-04 | 2013-09-05 | 9,000 | $69.00 | $621.0K | 37,950 | SEC↗ |
| ONTY Oncothyreon Inc. | S Sale | 2013-07-10 | 2014-10-08 | 3,403 | $1.72 | $5.9K | 20,644 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2013-07-01 | 2013-07-02 | 2,033 | $59.56 | $121.1K | 37,950 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2013-07-01 | 2013-07-02 | 2,033 | $60.00 | $122.0K | 39,983 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2013-06-19 | 2015-02-10 | 9 | $58.85 | $530 | 68,717 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2013-06-19 | 2015-02-10 | 9 | $58.57 | $527 | 68,708 | SEC↗ |
| ONTY Oncothyreon Inc. | A Award deriv | 2013-06-13 | 2013-06-14 | 16,042 | — | $0 | 16,042 | SEC↗ |
| ONTY Oncothyreon Inc. | F Tax w/h | 2013-06-09 | 2013-06-11 | 1,135 | $1.86 | $2.1K | 24,357 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2013-05-29 | 2013-05-30 | 4,184 | $64.46 | $269.7K | 42,016 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | A Award deriv | 2013-05-17 | 2013-05-20 | 100,000 | — | $0 | 100,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2013-05-15 | 2013-05-17 | 77,000 | — | $0 | 77,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2013-05-15 | 2013-05-17 | 13,200 | — | $0 | 46,200 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2013-05-01 | 2013-05-03 | 28,000 | — | $0 | 97,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2013-05-01 | 2013-05-03 | 28,000 | $39.06 | $1.09M | 61,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2013-05-01 | 2013-05-03 | 28,000 | $64.42 | $1.80M | 33,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2013-03-20 | 2015-02-10 | 5 | $61.99 | $310 | 68,695 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2013-03-20 | 2015-02-10 | 4 | $61.43 | $246 | 68,699 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2013-03-18 | 2015-02-10 | 7 | $61.38 | $430 | 68,690 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2013-03-18 | 2015-02-10 | 7 | $61.48 | $430 | 68,683 | SEC↗ |
| ONTY Oncothyreon Inc. | S Sale | 2013-02-20 | 2014-10-08 | 12,780 | $1.96 | $25.0K | 24,047 | SEC↗ |
| AFFY AFFYMAX INC | A Award deriv | 2012-06-13 | 2012-06-18 | 12,000 | — | $0 | 12,000 | SEC↗ |
| ONTY Oncothyreon Inc. | A Award | 2012-06-07 | 2012-06-08 | 8,174 | $3.67 | $30.0K | 25,492 | SEC↗ |
| ONTY Oncothyreon Inc. | F Tax w/h | 2012-06-03 | 2012-06-05 | 2,021 | $3.51 | $7.1K | 17,318 | SEC↗ |
| OMER OMEROS CORP | A Award deriv | 2012-06-01 | 2012-06-04 | 5,000 | — | $0 | 5,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2012-05-29 | 2012-05-31 | 125,000 | — | $0 | 125,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2012-05-29 | 2012-05-31 | 33,000 | — | $0 | 33,000 | SEC↗ |
| CYCC Cyclacel Pharmaceuticals, | A Award deriv | 2012-05-23 | 2012-05-24 | 35,000 | — | $0 | 35,000 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | A Award deriv | 2012-05-08 | 2012-05-10 | 12,000 | — | $0 | 12,000 | SEC↗ |